Accessibility links
Celebrex Linked to Heart Risk Pfizer says a study found an increased risk of heart problems with the painkiller Celebrex. The news comes after another painkiller, Vioxx, was withdrawn from the market. Like Vioxx, Celebrex is in a class of drugs called COX-2 inhibitors. Pfizer does not plan to pull Celebrex from the market. Hear NPR's Steve Inskeep and NPR's Richard Knox.

Health Care

Pfizer: Study Links Celebrex to Heart Problems

Heard on Morning Edition

Celebrex Linked to Heart Risk

Listen
  • Download
  • <iframe src="https://www.npr.org/player/embed/4233274/4233275" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Pfizer says a study found an increased risk of heart problems with the painkiller Celebrex. The news comes after another painkiller, Vioxx, was withdrawn from the market. Like Vioxx, Celebrex is in a class of drugs called COX-2 inhibitors. Pfizer does not plan to pull Celebrex from the market. Hear NPR's Steve Inskeep and NPR's Richard Knox.